The Benchmark Company Adds Industrial Research Team to Its Growing Platform NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced a significant expansion of its equity research platform, which includes the addition of four senior research...

Edward Rubin Joins the Benchmark Company as Co-Head of Investment Banking NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, a leading investment bank focused on capital markets, equity research and sales & trading for emerging and growth...

The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc. NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the closing of an Initial Public Offering for CNS Pharmaceuticals, Inc. of 2,125,000 shares of common stock at...

The Benchmark Company, LLC Announces Closing of Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock Offering for Youngevity International, Inc. NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC announced the closing on Sept. 24th of an underwritten public offering of 335,000 shares of 9.75% Series D Cumulative...